1. Brooks, P.M., Dick, W.C., Sharma, J.N., and Zeitlin, I.J.,Changes in plasma kininogen levels associated with rheumatoid activity, Br. J. Clin. Pharmac.1, 351P (1974).
2. Zeitlin, I.J., Sharma, J.N., Brooks, P.M., and Dick, W.C.,A effect of indomethacin on raised plasma kininogen levels in rheumatoid patients, in:Chemistry and Biology of the Kallikrein-Kinin System (Eds J.J. Pisano and K.F. Austen; US Govt. Printing Office, Washington, in press).
3. Lee, P., Webb, J., Anderson, J., and Buchanan, W. W.,Method for assessing therapeutic potential of anti-inflammatory anti-rheumatic drugs in rheumatoid arthritis, Br. med. J.2, 685 (1973).
4. Ritchie, D. M., Boyle, J. A., McInnes, J. M., Jasani, M. K., Dalakos, T.G., Grieveson, P., and Buchanan, W. W.,Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis, Q.J. Med.37 [NS], 393 (1973).
5. Brocklehurst, W. E., and Zeitlin, I. J.,Determination of plasma kinin and kininogen levels in man, J. Physiol., Lond.,191, 417 (1967).